Bad news about Kevetrin? What BS. Phase 1 is already a success for a primary outcomes. No trial is going to halt ever except to advance immediately to NDA review. The stuff is safe at triple the anticipated effective dose. Every approved trial will reach the protocol end points just based on safety, with or without efficacy.